Treatment on MRD: the category Natera Oncology Biopharma is building around treating at molecular relapse.
Design system
No palette in the brain yet.
No typefaces in the brain's tokens yet.
No palette yet
Artifacts
Ongoing projects
No project yet
A signed proposal becomes an ongoing project the work is measured against.
Knowledge base
0 notes in 0 folders
Sources
From the source register in the vault
No sources registered yet.
0 registered
Approvals
Nothing waiting
Items that need a human decision show up here.